Sexual Health

PT-141 vs Oxytocin: Two Central Peptides for Sexual Health

Verdict Summary

PT-141 activates melanocortin-4 receptors to enhance sexual desire and arousal. Oxytocin enhances bonding, trust, and arousal through different central pathways. Both work centrally and are often combined.

Medical Disclaimer: This comparison is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer →

At a Glance

DimensionPT-141Oxytocin
MechanismMelanocortin-4 receptor agonistOxytocin receptor activation
Primary EffectSexual desire and arousalBonding, trust, arousal
FDA StatusApproved (Vyleesi for women)Approved (various indications)
Duration6-12 hours1-2 hours (intranasal)

PT-141 Deep Dive

PT-141 directly activates melanocortin-4 receptors in the brain to enhance sexual desire and arousal. It is FDA approved for HSDD in premenopausal women and is used off-label in men.

Oxytocin Deep Dive

Oxytocin enhances bonding, trust, and sexual arousal through oxytocin receptors in the brain. Intranasal oxytocin has a rapid onset and short duration, making it suitable for use shortly before sexual activity.

How to Choose

Choose PT-141 if…

  • Sexual desire is the primary concern
  • You want the longer-lasting effect
  • FDA approval for sexual health is important

Choose Oxytocin if…

  • Bonding and emotional intimacy are also goals
  • Rapid onset and short duration are preferred
  • You want to enhance the emotional connection aspect of sexuality

Consider Both If…

PT-141 + oxytocin is used by some to address both desire (PT-141) and bonding/intimacy (oxytocin) simultaneously.

Still Unsure?

Get a personalized recommendation

Take the 5-minute PeptidePilot quiz. Our algorithm evaluates your goals, body, and lifestyle to recommend the right peptide for you — vendor-neutral.

Frequently Asked Questions

More Comparisons